Rintatolimod
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Rintatolimod, covering 2020-02-10 to 2026-02-25. Get the full timeline:
Most recent: Clinical Trial Update: Polarized Dendritic Cell (aDC1) Based Treatment, Interferon Alpha-2, Rintatolimod, and Celecoxib for the Treatment of HLA-A2+ Refractory Melanoma [Phase 2]